|
1
|
Qin XJ and Ling BX: Proteomic studies in
breast cancer (Review). Oncol Lett. 3:735–743. 2012.PubMed/NCBI
|
|
2
|
Spinelli GP, Russo LG, Miele E, et al:
Breast cancer metastatic to the pituitary gland: a case report.
World J Surg Oncol. 10:1372012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gnant M, Balic M, Petru E, et al:
Treatment of bone metastases in patients with advanced breast
cancer. Breast Care (Basel). 7:92–98. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Breidenbach M, Rein DT, Schondorf T, et
al: A new targeting approach for breast cancer gene therapy using
the heparanase promoter. Cancer Lett. 240:114–122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Coleman RE: Clinical features of
metastatic bone disease and risk of skeletal morbidity. Clin Cancer
Res. 12:6243–6249. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fux L, Ilan N, Sanderson RD and Vlodavsky
I: Heparanase: busy at the cell surface. Trends Biochem Sci.
34:511–519. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vlodavsky I, Elkin M, Pappo O, et al:
Mammalian heparanase as mediator of tumor metastasis and
angiogenesis. Isr Med Assoc. 2:37–45. 2000.PubMed/NCBI
|
|
8
|
Yang Y, Macleod V, Bendre M, et al:
Heparanase promotes the spontaneous metastasis of myeloma cells to
bone. Blood. 105:1303–1309. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baraz L, Haupt Y, Elkin M, Peretz T and
Vlodavsky I: Tumor suppressor p53 regulates heparanase gene
expression. Oncogene. 25:3939–3947. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cohen I, Maly B, Simon I, et al: Tamoxifen
induces heparanase expression in estrogen receptor-positive breast
cancer. Clin Cancer Res. 13:4069–4077. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang F, Wang Y, Kim MS, et al:
Glucose-induced endothelial heparanase secretion requires cortical
and stress actin reorganization. Cardiovasc Res. 87:127–136. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vitale FV, Rotondo S, Sessa E, et al: Low
molecular weight heparin administration in cancer patients with
hypercoagulability-related complications and carrying brain
metastases: a case series study. J Oncol Pharm Pract. 18:10–16.
2011. View Article : Google Scholar
|
|
13
|
Gandhi NS, Freeman C, Parish CR and
Mancera RL: Computational analyses of the catalytic and
heparin-binding sites and their interactions with
glycosaminoglycans in glycoside hydrolase family 79
endo-β-D-glucuronidase (heparanase). Glycobiology. 22:35–55.
2012.PubMed/NCBI
|
|
14
|
Schroder M and Kaufman RJ: The mammalian
unfolded protein response. Annu Rev Biochem. 74:739–789. 2005.
View Article : Google Scholar
|
|
15
|
Takada A, Miki T, Kuno A, et al: Role of
ER stress in ventricular contractile dysfunction in type 2
diabetes. PLoS One. 7:e398932012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li N, Zoubeidi A, Beraldi E and Gleave ME:
GRP78 regulates clusterin stability, retrotranslocation and
mitochondrial localization under ER stress in prostate cancer.
Oncogene. June 11–2012.(Epub ahead of print).
|
|
17
|
Dong D, Ni M, Li J, et al: Critical role
of the stress chaperone GRP78/BiP in tumor proliferation, survival,
and tumor angiogenesis in transgene-induced mammary tumor
development. Cancer Res. 68:498–505. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weng WC, Lee WT, Hsu WM, Chang BE and Lee
H: Role of glucose-regulated Protein 78 in embryonic development
and neurological disorders. J Formos Med Assoc. 110:428–437. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nasser NJ, Sarig G, Brenner B, et al:
Heparanase neutralizes the anticoagulation properties of heparin
and low-molecular-weight heparin. J Thromb Haemost. 4:560–565.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang Y, O’Driscoll L, McDonnell S, et al:
Enhanced in vitro invasiveness and drug resistance with altered
gene expression patterns in a human lung carcinoma cell line after
pulse selection with anticancer drugs. Int J Cancer. 111:484–493.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bruzzi P, Del Mastro L, Sormani MP, et al:
Objective response to chemotherapy as a potential surrogate end
point of survival in metastatic breast cancer patients. J Clin
Oncol. 23:5117–5125. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ilan NM, Elkin and Vlodavsky I:
Regulation, function and clinical significance of heparanase in
cancer metastasis and angiogenesis. Int J Biochem Cell Biol.
38:2018–2039. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meirovitz A, Hermano E, Lerner I, et al:
Role of heparanase in radiation-enhanced invasiveness of pancreatic
carcinoma. Cancer Res. 71:2772–2780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nasser NJ: Heparanase involvement in
physiology and disease. Cell Mol Life Sci. 65:1706–1715. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Theocharis AD, Skandalis SS, Tzanakakis GN
and Karamanos NK: Proteoglycans in health and disease: novel roles
for proteoglycans in malignancy and their pharmacological
targeting. FEBS J. 277:3904–3923. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fan L, Wu Q, Xing X, Liu Y and Shao Z:
Targeted silencing of heparanase gene by small interfering RNA
inhibits invasiveness and metastasis of osteosarcoma cells. J
Huazhong Univ Sci Technolog Med Sci. 31:348–352. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vlodavsky I, Beckhove P, Lerner I, et al:
Significance of heparanase in cancer and inflammation. Cancer
Microenviron. 5:115–132. 2011. View Article : Google Scholar
|
|
28
|
Su R, Li Z, Li H, et al: Grp78 promotes
the invasion of hepatocellular carcinoma. BMC Cancer. 10:202010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scull CM and Tabas I: Mechanisms of ER
stress-induced apoptosis in atherosclerosis. Arterioscler Thromb
Vasc Biol. 31:2792–2797. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nishitoh H: CHOP is a multifunctional
transcription factor in the ER stress response. J Biochem.
151:217–219. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang KH, Kuo KL, Chen SC, et al:
Down-regulation of glucose-regulated protein (GRP) 78 potentiates
cytotoxic effect of celecoxib in human urothelial carcinoma cells.
PLoS One. 7:e336152012. View Article : Google Scholar
|
|
32
|
Feng X, Krishnan K, Richie DL, et al:
HacA-independent functions of the ER stress sensor IreA synergize
with the canonical UPR to influence virulence traits in
Aspergillus fumigatus. PLoS Pathog. 7:e10023302011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fribley AM, Miller JR, Reist TE, Callaghan
MU and Kaufman RJ: Large-scale analysis of UPR-mediated apoptosis
in human cells. Methods Enzymol. 491:57–71. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fiamoli V, Blatny J, Zapleta O, Kohlerova
S and Janousova E: Treatment of deep vein thrombosis with
continuous IV infusion of LMWH: a retrospective study in 32
children. Thrombosis. 2011:9814972011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhao H, Liu H, Chen Y, et al:
Oligomannurarate sulfate, a novel heparanase inhibitor
simultaneously targeting basic fibroblast growth factor, combats
tumor angiogenesis and metastasis. Cancer Res. 66:8779–8787. 2006.
View Article : Google Scholar
|
|
36
|
Basche M, Gustafson DL, Holden SN, et al:
A phase I biological and pharmacologic study of the heparanase
inhibitor PI-88 in patients with advanced solid tumors. Clin Cancer
Res. 12:5471–5480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu YZ, Zhu Y, Shen ZJ, et al: Significance
of heparanase-1 and vascular endothelial growth factor in
adrenocortical carcinoma angiogenesis: potential for therapy.
Endocrine. 40:445–451. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sanderson RD and Iozzo RV: Targeting
heparanase for cancer therapy at the tumor-matrix interface. Matrix
Biol. 31:283–284. 2012. View Article : Google Scholar : PubMed/NCBI
|
